Sharing is caring!

China’s state media, Xinhua reported on April 14 that the Government has approved two experimental vaccines for early-stage human tests against COVID-19 that have led to over 100,000 fatalities worldwide.

The vaccines are being developed by a Beijing-based unit of Nasdaq-listed Sinovac Biotech, and by the Wuhan Institute of Biological Products, an affiliate of state-owned China National Pharmaceutical Group.

Back in March, China also approved a clinical trial for a COVID-19 vaccine candidate developed by military-backed China’s Academy of Military Medical Sciences and HK-listed biotech firm CanSino Bio and has since then achieved development milestones.

(Source: Straits Times, 2020)